<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-30T04:43:08Z</responseDate><request verb="GetRecord" identifier="oai:riuma.uma.es:10630/37389" metadataPrefix="qdc">https://riuma.uma.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:riuma.uma.es:10630/37389</identifier><datestamp>2026-02-03T11:45:12Z</datestamp><setSpec>com_10630_2254</setSpec><setSpec>col_10630_37956</setSpec></header><metadata><qdc:qualifieddc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:qdc="http://dspace.org/qualifieddc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://dspace.org/qualifieddc/ http://www.ukoln.ac.uk/metadata/dcmi/xmlschema/qualifieddc.xsd">
   <dc:title>Extracellular Matrix-Remodeling Enzymes as Targets for Natural Antiangiogenic Compounds</dc:title>
   <dc:creator>Carrillo, Paloma</dc:creator>
   <dc:creator>García-Caballero, Melissa</dc:creator>
   <dc:creator>Bernal, Manuel</dc:creator>
   <dc:creator>Manrique-Poyato, María Inmaculada</dc:creator>
   <dc:creator>Martínez-Póveda, Beatriz Amparo</dc:creator>
   <dc:creator>Rodríguez-Quesada, Ana María</dc:creator>
   <dc:creator>Medina-Torres, Miguel Ángel</dc:creator>
   <dc:contributor>Karamanos, Nikos</dc:contributor>
   <dc:subject>Neovascularización</dc:subject>
   <dcterms:abstract>Angiogenesis, or new blood vessels formation, comprises a series of&#xd;
tight regulated and coordinated steps guided by the balance between proangiogenic&#xd;
and antiangiogenic signals. Although physiological angiogenesis occurs in some&#xd;
context such as embryogenesis or wound healing, it is a very restricted process in&#xd;
adults, therefore, it is associated to several pathologies as cancer, arthritis or age-&#xd;
related macular degeneration. For this purpose, plenty of compounds from natural&#xd;
sources have been studied and their antiangiogenic potential has been demonstrated.&#xd;
Most of them are isolated from plants, such as the major catechin found in green tea&#xd;
epigallocatechin-3-gallate (EGCG) or the isoflavonoid genistein. Nevertheless,&#xd;
compounds with antiangiogenic potential can be found in several species of&#xd;
animals, fungi, algae or bacteria, for instance, aeroplysinin-1, AD0157, carrageenan&#xd;
derivates and rapamycin, respectively. The extracellular matrix (ECM) remodeling&#xd;
plays a key role in the formation of new blood vessels. The degradation of the ECM&#xd;
components not only provides a structural scaffold for the nascent vessels, but it is&#xd;
also strongly involved in endothelial cell signaling, promoting or inhibiting this&#xd;
complex process. In this regard, targeting the ECM components entails an&#xd;
interesting therapeutic strategy for the treatment of angiogenesis-related diseases.&#xd;
This book chapter is an updated overview of natural compounds with an&#xd;
antiangiogenic effect with the capability to target one or more EMC components.</dcterms:abstract>
   <dcterms:dateAccepted>2025-01-30T11:20:02Z</dcterms:dateAccepted>
   <dcterms:available>2025-01-30T11:20:02Z</dcterms:available>
   <dcterms:created>2025-01-30T11:20:02Z</dcterms:created>
   <dcterms:issued>2022-12</dcterms:issued>
   <dc:type>book part</dc:type>
   <dc:identifier>https://hdl.handle.net/10630/37389</dc:identifier>
   <dc:identifier>10.1007/978-3-031-19616-4_6</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:rights>open access</dc:rights>
   <dc:publisher>Springer Nature Switzerland</dc:publisher>
</qdc:qualifieddc>
</metadata></record></GetRecord></OAI-PMH>